Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥25,169 | ¥22,894 | ¥25,893 | ¥30,013 |
| Short-Term Investments | ¥23,485 | ¥23,039 | ¥23,706 | ¥23,139 |
| Receivables | ¥29,653 | ¥28,679 | ¥22,806 | ¥22,806 |
| Inventory | ¥24,979 | ¥26,296 | ¥22,798 | ¥18,987 |
| Other Curr. Assets | ¥3,694 | ¥3,643 | ¥5,438 | ¥4,397 |
| Total Curr. Assets | ¥106,980 | ¥104,551 | ¥100,641 | ¥99,342 |
| Property Plant & Equip (Net) | ¥27,069 | ¥24,861 | ¥24,579 | ¥24,074 |
| Goodwill | ¥242 | ¥309 | ¥0 | ¥0 |
| Intangibles | ¥1,652 | ¥1,683 | ¥1,507 | ¥1,569 |
| Long-Term Investments | ¥84,874 | ¥106,366 | ¥51,063 | ¥96,634 |
| Tax Assets | ¥566 | ¥608 | ¥433 | ¥524 |
| Other NC Assets | ¥22,676 | ¥22,551 | ¥42,974 | ¥15,941 |
| Total NC Assets | ¥137,079 | ¥156,378 | ¥120,556 | ¥138,742 |
| Other Assets | ¥0 | ¥5 | ¥3 | ¥3 |
| Total Assets | ¥244,059 | ¥260,929 | ¥221,200 | ¥238,087 |
| Liabilities | – | – | – | – |
| Payables | ¥4,602 | ¥4,893 | ¥4,617 | ¥4,104 |
| Short-Term Debt | ¥1,280 | ¥1,340 | ¥1,490 | ¥1,640 |
| Tax Payable | ¥0 | ¥2,380 | ¥408 | ¥3,497 |
| Deferred Revenue | ¥1,033 | ¥1,486 | ¥4,082 | ¥8,051 |
| Other Curr. Liab. | ¥9,663 | ¥7,564 | ¥4,360 | ¥1,452 |
| Total Curr. Liab. | ¥16,578 | ¥17,663 | ¥14,957 | ¥18,744 |
| LT Debt | ¥166 | ¥0 | ¥0 | ¥0 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥16,481 | ¥21,188 | ¥10,426 | ¥16,259 |
| Other NC Liab. | ¥705 | ¥944 | ¥1,004 | ¥906 |
| Total NC Liab. | ¥17,352 | ¥22,132 | ¥11,430 | ¥17,165 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥166 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥33,930 | ¥39,795 | ¥26,387 | ¥35,909 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥161,247 | ¥153,854 |
| Common Stock | ¥24,356 | ¥24,356 | ¥24,356 | ¥24,356 |
| Retained Earnings | ¥131,488 | ¥127,310 | ¥125,576 | ¥118,183 |
| AOCI | ¥43,453 | ¥57,344 | ¥32,652 | ¥47,530 |
| Other Equity | ¥9,707 | ¥11,017 | ¥11,314 | ¥11,314 |
| Total Equity | ¥209,004 | ¥220,027 | ¥193,899 | ¥201,384 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥1,122 | ¥1,107 | ¥914 | ¥794 |
| Total Liab. & Tot. Equity | ¥244,059 | ¥260,929 | ¥221,200 | ¥238,087 |
| Net Debt | -¥23,723 | -¥21,554 | -¥24,403 | -¥28,373 |